Your browser doesn't support javascript.
loading
Clinical experience following implementation of routine SPECT-CT imaging following 131-iodine administration for thyroid cancer.
Ahmadi, Sara; Coleman, Alexandra; de Morais, Nathalie Silva; Landa, Iñigo; Pappa, Theodora; Kang, Alex; Kim, Matthew I; Marqusee, Ellen; Alexander, Erik K.
Afiliação
  • Ahmadi S; Thyroid Section Brigham & Women's Hospital & Harvard Medical School, Boston, Massachusetts, USA.
  • Coleman A; Thyroid Section Brigham & Women's Hospital & Harvard Medical School, Boston, Massachusetts, USA.
  • de Morais NS; Thyroid Section Brigham & Women's Hospital & Harvard Medical School, Boston, Massachusetts, USA.
  • Landa I; Endocrinology Service, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
  • Pappa T; Thyroid Section Brigham & Women's Hospital & Harvard Medical School, Boston, Massachusetts, USA.
  • Kang A; Thyroid Section Brigham & Women's Hospital & Harvard Medical School, Boston, Massachusetts, USA.
  • Kim MI; Thyroid Section Brigham & Women's Hospital & Harvard Medical School, Boston, Massachusetts, USA.
  • Marqusee E; Thyroid Section Brigham & Women's Hospital & Harvard Medical School, Boston, Massachusetts, USA.
  • Alexander EK; Thyroid Section Brigham & Women's Hospital & Harvard Medical School, Boston, Massachusetts, USA.
Endocr Connect ; 11(5)2022 May 25.
Article em En | MEDLINE | ID: mdl-35521806

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article